The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. CommentaryKRAMBECK, Amy E; LEIBOVICH, Bradley C; LOHSE, Christine M et al.The Journal of urology. 2006, Vol 176, Num 5, pp 1990-1995, issn 0022-5347, 6 p.Article

Eastern cooperative oncology group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: Implication for preoperative bone scansSHVARTS, Oleg; LAM, John S; KIM, Hyung L et al.The Journal of urology. 2004, Vol 172, Num 3, pp 867-870, issn 0022-5347, 4 p.Article

Differences in Organ System of Distant Metastasis by Renal Cell Carcinoma SubtypeHOFFMANN, Nathan E; GILLETT, Michael D; CHEVILLE, John C et al.The Journal of urology. 2008, Vol 179, Num 2, pp 474-477, issn 0022-5347, 4 p.Article

Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomyLEIBOVICH, Bradley C; BLUTE, Michael L; CHEVILLE, John C et al.The Journal of urology. 2004, Vol 171, Num 3, pp 1066-1070, issn 0022-5347, 5 p.Article

Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor IYOSHIMURA, Ichiro; MIZUGUCHI, Yasunori; MIYAJIMA, Akira et al.The Journal of urology. 2004, Vol 171, Num 6, pp 2467-2470, issn 0022-5347, 4 p., 1Article

Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinomaJUNG, Klaus; LEIN, Michael; RINGSDORF, Martin et al.The Journal of urology. 2006, Vol 176, Num 4, pp 1326-1331, issn 0022-5347, 6 p., 1Article

Surgical Resection of Isolated Retroperitoneal Lymph Node Recurrence of Renal Cell Carcinoma Following Nephrectomy. CommentaryBOORJIAN, Stephen A; CRISPEN, Paul L; LOHSE, Christine M et al.The Journal of urology. 2008, Vol 180, Num 1, pp 99-103, issn 0022-5347, 5 p.Article

A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma : A stratification tool for prospective clinical trials. CommentaryLEIBOVICH, Bradley C; CHEVILLE, John C; LOHSE, Christine M et al.The Journal of urology. 2005, Vol 174, Num 5, pp 1759-1763, issn 0022-5347, 5 p.Article

A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents. CommentaryTANNIR, Nizar M; THALL, Peter F; STADLER, Walter et al.The Journal of urology. 2008, Vol 180, Num 3, pp 867-872, issn 0022-5347, 6 p.Article